Stocks making the biggest moves midday: Moderna, Robinhood, BJ's Wholesale, Coinbase & more
BJ's Wholesale shares rose 4% after Q2 earnings beat estimates, with revenue at $6.09B and EPS guidance raised. Ross Stores also gained over 4% on strong Q2 results and upbeat Q3 guidance. Crypto-related stocks like Robinhood and Coinbase surged as bitcoin climbed over 20% for the week. Broadcom rose 1% on reports of a $60B debt plan for a deal. OSI Systems dropped 10% after missing revenue expectations. The Boston Beer Company fell 3% following CFO departure news. O-I Glass jumped 10% after a C
How this was made
The 30-second read
Why it matters
The article aggregates primary earnings beats, analyst upgrades, and a major biotech trial win, providing multiple short‑term trading opportunities.
Market read
The mix of earnings surprises, analyst upgrades, and crypto momentum creates actionable signals across several sectors.
What to watch
Potential supply‑chain constraints for biotech and semiconductor sectors not discussed.
Background
Midday market roundup highlighting the biggest price moves and fresh corporate news.
Ticker impact
Ross Stores posted Q2 results above expectations and issued strong Q3 guidance, lifting the stock over 4%.
Expect modest upside, ~5% over the next few days.
First report of earnings beat and guidance.
Robinhood surged 12% as crypto stocks rallied on Bitcoin's price rise and White House crypto initiative.
Short-term upside of 8‑10% possible.
Move driven by broader crypto sentiment, not a company‑specific event.
Coinbase gained more than 8% amid Bitcoin's strong performance and White House crypto push.
Potential 7‑9% rally in the near term.
Same catalyst as Robinhood; market‑wide crypto move.
Broadcom rose ~1% after Bloomberg reported it may raise $60B debt for an Anthropic deal.
Limited move, ~2‑3% upside.
Report is speculative, not a confirmed transaction.
OSI Systems fell almost 10% after Q4 revenue missed expectations.
Further downside possible, 5‑7% decline.
Fresh earnings miss is primary news.
O‑I Glass jumped 10% after Citi upgraded the stock and raised the price target.
Expect 8‑12% upside in the short term.
Upgrade with target is fresh actionable news.
Moderna surged >10% after a Merck‑Moderna cancer vaccine showed positive late‑stage trial results.
Potential 20‑30% move over the next weeks.
Clinical trial result is primary, high‑impact news.
Merck rose 2% as its partner vaccine with Moderna reported positive trial data.
Small upside, ~3‑4% expected.
Indirect benefit from partner's trial.
Market effects
Strong earnings beats lift retail and consumer discretionary sectors; crypto rally boosts fintech and exchange platforms.
U.S. equities see broad gains; crypto sentiment influences global digital asset markets.
Positive biotech trial data and crypto policy news have worldwide relevance.
Counterpoint
Some upgrades may be premature; crypto rally could reverse on regulatory setbacks.
Key entities
- CompanyBJ's Wholesale
Retail wholesale operator
- CompanyModerna
Biotech firm with cancer vaccine trial
- CompanyRobinhood
Retail trading platform
